Target intelligence / Profile preview

Cellular protein sulfhydryl systems (multiple cysteine-containing proteins)

Molecular classification
Other
01

Overview

Cellular protein sulfhydryl systems, comprising a diverse array of multiple cysteine-containing proteins, represent a critical pharmacological and toxicological target (DrugBank DB00954; T3DB T3D0011). Cysteine residues, with their reactive thiol (-SH) groups, are essential for the catalytic activity of many enzymes, the structural stability of proteins via disulfide bonds, and the maintenance of cellular redox homeostasis (PubMed: 21953168). Heavy metals such as mercury, arsenic, and lead exhibit a high affinity for these sulfhydryl groups, forming stable covalent mercaptides that can lead to protein denaturation and enzyme inhibition. This interaction is the primary mechanism underlying the systemic toxicity of heavy metal poisoning. Additionally, certain therapeutic agents like cisplatin and ethacrynic acid target these systems to exert their effects, while chelating agents like dimercaprol are used to protect these cellular thiols by sequestering toxic metals. The bioactivation of drugs like nitroglycerin also depends on the availability of these cellular sulfhydryl groups (PubMed: 17606654). The integrity of these sulfhydryl systems is vital for cellular survival, and their disruption is a hallmark of oxidative stress and various metabolic disorders.

Other names
Protein thiolsSulfhydryl groupsCellular thiol poolProtein sulfhydrylsCysteine-rich proteinsProtein sulfhydryl systems
02

Mechanism of action

Covalent binding of electrophilic agents or heavy metal ions to the sulfur atom of cysteine residues (thiol/sulfhydryl groups), leading to protein denaturation, enzyme inactivation, or disruption of redox signaling.

03

Biological functions

Redox signalingAntioxidant defenseEnzyme catalysisMetal homeostasisProtein foldingStructural stability (disulfide bond formation)
04

Disease associations

Heavy metal poisoningOxidative stressCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Non-specific systemic toxicityIrreversible protein modificationDepletion of cellular antioxidant capacityPotential for widespread metabolic disruption
06

Interacting drugs

Mercury

10 more in the full profile.

07

Biomarkers

Reduced glutathione (GSH) levelsProtein carbonyl contentBlood mercury levelsUrinary arsenic levelsDelta-aminolevulinic acid dehydratase (ALAD) activityZinc protoporphyrin

Beyond the preview

Go deeper on Cellular protein sulfhydryl systems (multiple cysteine-containing proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular protein sulfhydryl systems (multiple cysteine-containing proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call